Montelukast is a dual-purpose inhibitor of SARS-CoV-2 infection and virus-induced IL-6 expression identified by structure-based drug repurposing
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Montelukast is a dual-purpose inhibitor of SARS-CoV-2 infection and virus-induced IL-6 expression identified by structure-based drug repurposing
Authors
Keywords
-
Journal
Computational and Structural Biotechnology Journal
Volume 20, Issue -, Pages 799-811
Publisher
Elsevier BV
Online
2022-01-29
DOI
10.1016/j.csbj.2022.01.024
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- COVID-19 and the human innate immune system
- (2021) Joachim L. Schultze et al. CELL
- Interleukin-6 Receptor Inhibition in Covid-19 — Cooling the Inflammatory Soup
- (2021) Eric J. Rubin et al. NEW ENGLAND JOURNAL OF MEDICINE
- Dipyridamole, chloroquine, montelukast sodium, candesartan, oxytetracycline, and atazanavir are not SARS-CoV-2 main protease inhibitors
- (2021) Chunlong Ma et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Multilevel proteomics reveals host perturbations by SARS-CoV-2 and SARS-CoV
- (2021) Alexey Stukalov et al. NATURE
- Comprehensive Consensus Analysis of SARS-CoV-2 Drug Repurposing Campaigns
- (2021) Hazem Mslati et al. Journal of Chemical Information and Modeling
- SARS-CoV-2-specific hotspots in virus–host interaction networks
- (2021) Herbert B. Schiller et al. NATURE IMMUNOLOGY
- SARS-CoV-2 variants, spike mutations and immune escape
- (2021) William T. Harvey et al. NATURE REVIEWS MICROBIOLOGY
- Drug-induced phospholipidosis confounds drug repurposing for SARS-CoV-2
- (2021) Tia A. Tummino et al. SCIENCE
- A high-throughput screen for TMPRSS2 expression identifies FDA-approved compounds that can limit SARS-CoV-2 entry
- (2021) Yanwen Chen et al. Nature Communications
- Structural basis for the recognition of the SARS-CoV-2 by full-length human ACE2
- (2020) Renhong Yan et al. SCIENCE
- Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation
- (2020) Daniel Wrapp et al. SCIENCE
- Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein
- (2020) Alexandra C. Walls et al. CELL
- SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor
- (2020) Markus Hoffmann et al. CELL
- Probable Pangolin Origin of SARS-CoV-2 Associated with the COVID-19 Outbreak
- (2020) Tao Zhang et al. CURRENT BIOLOGY
- In-silico approaches to detect inhibitors of the human severe acute respiratory syndrome coronavirus envelope protein ion channel
- (2020) Manoj Kumar Gupta et al. JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS
- Baricitinib for COVID-19: a suitable treatment?
- (2020) Ennio G Favalli et al. LANCET INFECTIOUS DISEASES
- An open-source drug discovery platform enables ultra-large virtual screens
- (2020) Christoph Gorgulla et al. NATURE
- Structure of the SARS-CoV-2 spike receptor-binding domain bound to the ACE2 receptor
- (2020) Jun Lan et al. NATURE
- Severe Covid-19
- (2020) David A. Berlin et al. NEW ENGLAND JOURNAL OF MEDICINE
- Compassionate Use of Remdesivir for Patients with Severe Covid-19
- (2020) Jonathan Grein et al. NEW ENGLAND JOURNAL OF MEDICINE
- Cell entry mechanisms of SARS-CoV-2
- (2020) Jian Shang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- A human monoclonal antibody blocking SARS-CoV-2 infection
- (2020) Chunyan Wang et al. Nature Communications
- A search for medications to treat COVID-19 via in silico molecular docking models of the SARS-CoV-2 spike glycoprotein and 3CL protease
- (2020) Donald C. Hall et al. Travel Medicine and Infectious Disease
- Network-based drug repurposing for novel coronavirus 2019-nCoV/SARS-CoV-2
- (2020) Yadi Zhou et al. Cell Discovery
- Clinical and Epidemiological Features of a Family Cluster of Symptomatic and Asymptomatic SARS-CoV-2 Infection
- (2020) Gerhard K Wolf et al. Journal of the Pediatric Infectious Diseases Society
- The FDA-approved drug ivermectin inhibits the replication of SARS-CoV-2 in vitro
- (2020) Leon Caly et al. ANTIVIRAL RESEARCH
- Longitudinal analyses reveal immunological misfiring in severe COVID-19
- (2020) Carolina Lucas et al. NATURE
- Distinct conformational states of SARS-CoV-2 spike protein
- (2020) Yongfei Cai et al. SCIENCE
- Exploring the SARS-CoV-2 virus-host-drug interactome for drug repurposing
- (2020) Sepideh Sadegh et al. Nature Communications
- Proteolytic Cleavage of the SARS-CoV-2 Spike Protein and the Role of the Novel S1/S2 Site
- (2020) Javier A. Jaimes et al. iScience
- COVID-19 vaccine BNT162b1 elicits human antibody and TH1 T cell responses
- (2020) Ugur Sahin et al. NATURE
- A dynamic COVID-19 immune signature includes associations with poor prognosis
- (2020) Adam G. Laing et al. NATURE MEDICINE
- A Global Ramachandran Score Identifies Protein Structures with Unlikely Stereochemistry
- (2020) Oleg V. Sobolev et al. STRUCTURE
- Drug ReposER: a web server for predicting similar amino acid arrangements to known drug binding interfaces for potential drug repositioning
- (2019) Nur Syatila Ab Ghani et al. NUCLEIC ACIDS RESEARCH
- SWISS-MODEL: homology modelling of protein structures and complexes
- (2018) Andrew Waterhouse et al. NUCLEIC ACIDS RESEARCH
- Drug repurposing: progress, challenges and recommendations
- (2018) Sudeep Pushpakom et al. NATURE REVIEWS DRUG DISCOVERY
- PockDrug-Server: a new web server for predicting pocket druggability on holo and apo proteins
- (2015) Hiba Abi Hussein et al. NUCLEIC ACIDS RESEARCH
- g_mmpbsa—A GROMACS Tool for High-Throughput MM-PBSA Calculations
- (2014) Rashmi Kumari et al. Journal of Chemical Information and Modeling
- Cysteinyl Leukotriene Receptor-1 Antagonists as Modulators of Innate Immune Cell Function
- (2014) A. J. Theron et al. Journal of Immunology Research
- Drug Promiscuity in PDB: Protein Binding Site Similarity Is Key
- (2013) V. Joachim Haupt et al. PLoS One
- Improving the Physical Realism and Structural Accuracy of Protein Models by a Two-Step Atomic-Level Energy Minimization
- (2011) Dong Xu et al. BIOPHYSICAL JOURNAL
- SwissParam: A fast force field generation tool for small organic molecules
- (2011) Vincent Zoete et al. JOURNAL OF COMPUTATIONAL CHEMISTRY
- Automated minimization of steric clashes in protein structures
- (2010) Srinivas Ramachandran et al. PROTEINS-STRUCTURE FUNCTION AND BIOINFORMATICS
- Clinical Pharmacokinetics and Pharmacodynamics of Tigecycline
- (2009) April Barbour et al. CLINICAL PHARMACOKINETICS
- AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibility
- (2009) Garrett M. Morris et al. JOURNAL OF COMPUTATIONAL CHEMISTRY
- Absorption of montelukast is transporter mediated: a common variant of OATP2B1 is associated with reduced plasma concentrations and poor response
- (2009) Edward B. Mougey et al. Pharmacogenetics and Genomics
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started